putty
-
Spine
NovaBone Receives FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications
November 12, 2024 – NovaBone Products, a leader in synthetic bone graft solutions, has announced its latest milestone: FDA clearance…
Read More » -
Biologics
Ventris Medical Receives 510(k) Additional Clearance for Amplify® Standalone Bone Graft Putty
Amplify® – Activated Bone Graft NEWPORT BEACH, Calif., March 13, 2024 /PRNewswire/ — Ventris Medical, a privately held orthobiologics and tissue regeneration…
Read More » -
Regulatory
SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft
BOCA RATON, Fla., March 7, 2024–(BUSINESS WIRE)–SurGenTec, a pioneering medical device company specializing in orthopedic and spine technologies, proudly announces…
Read More » -
Biologics
CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market
The first Korean developed medical device for spine implantation Expecte to receive faster approval in the U.S. by priority support…
Read More » -
Biologics
Abyrx Receives Additional FDA Clearances for MONTAGE® Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
STAMFORD, Conn., April 5, 2023 /PRNewswire/ — Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for…
Read More » -
Biologics
Ventris Medical Receives 510(k) Clearance for Amplify® Standalone Bone Graft Putty and Bone Graft Extender
NEWPORT BEACH, Calif., Sept. 14, 2022 /PRNewswire/ — Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
SIRAKOSS Receives U.S. FDA 510(k) Clearance for Osteo3 ZP Putty to Catalyse Rapid and Complete Bone Regeneration
Aberdeen, UK, 17 June 2020 – SIRAKOSS Ltd, a developer of nanosynthetic bone graft substitutes, announced today that it has received…
Read More » -
Biologics
Randomized Controlled Trial Results Published in ‘Spine’ Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion
– Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate…
Read More » -
Biologics
Isto Biologics Introduces New Influx DBM Putty
HOPKINTON, Mass. – September 5, 2019 – (Newswire.com) Isto Biologics, an orthobiologics company dedicated to improving patient quality of life,…
Read More » -
Spine
Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty
BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Biologics
Synergy Biomedical Announces Expanded FDA Clearance of BIOSPHERE PUTTY for Spine Indications
COLLEGEVILLE, Pa.–(BUSINESS WIRE)–Synergy Biomedical, LLC, a developer of novel biomaterial products, announced today that it has received 510(k) clearance from…
Read More » -
Biologics
BioStructures, LLC Receives 510(k) Clearance for Innovative Bioactive Bone Graft Putty and Bone Graft Extender.
NEWPORT BEACH, Calif., Feb. 18, 2014 /PRNewswire/ — BioStructures, LLC, a privately held orthobiologics company, today announced that the United States Food…
Read More »